Dexamethasone-treated and monophosphoryl lipid a-activated dendritic cells induce antigen-specific naive CD4+ T cells hyporesponsiveness

dc.date.accessioned2019-03-27T15:58:43Z
dc.date.accessioned2022-10-18T22:14:21Z
dc.date.available2019-03-27T15:58:43Z
dc.date.available2022-10-18T22:14:21Z
dc.date.created2019-03-27T15:58:43Z
dc.date.issued2014
dc.identifierhttp://hdl.handle.net/10533/234546
dc.identifier1140553
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4465903
dc.description.abstractIntroduction: Dendritic cells (DCs) are antigen-presenting cells that initiate and modulate adaptive immune responses, inducing either immunity or tolerance. In vitro generated DCs with tolerogenic properties are promising therapeutic tools to control T c
dc.languageeng
dc.relation28°
dc.relationinfo:eu-repo/grantAgreement/Fondecyt/1140553
dc.relationReunión Anual de La Sociedad de Biología Celular De Chile
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleDexamethasone-treated and monophosphoryl lipid a-activated dendritic cells induce antigen-specific naive CD4+ T cells hyporesponsiveness
dc.typePonencia


Este ítem pertenece a la siguiente institución